Metabolism and fate of xeno-oestrogens in man

Pure and Applied Chemistry

Volumn 70, Issue 9, 1998, Pages 1747-1758

  Liehr, J G ^a,b   Somasunderam, A ^a   Roy, D ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Stehlin Found for Cancer Research   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000180140     PISSN: 00334545     EISSN: None     Source Type: Journal    
DOI: 10.1351/pac199870091747     Document Type: Article

References (34)

1. Roy, D., Palangat, M, Chen, C-W, Thomas, RD, Colerangle, JC, Atkinson, A, and Yan, ZJ. Biochemical and molecular changes at the cellular level in response to exposure to environmental oestrogen-like chemicals. J. Toxicol. Env. Health, 1997, 50, 1-29.
2. Kiessling KH AND Pettersson H. Metabolism of zearalenone in rat liver. Acta Pharmacol. Toxicol. 1978, 43, 285-290.
3. Chang W-M and Lin J-K. Transformation of zearalenone and zearalenol by rat erythrocytes. Food Chem. Toxic. 1984, 22, 887-891.
4. Li, JJ, Li, SA, Klicka, JK and Heller, JA. Some biological and toxicological studies of various mycotoxins and phyto-oestrogens. In: Oestrogens in the Environment (Ed. J.A. McLachlan) Elsevier Science Publishing Co., Inc., New York, pp 168-181, 1985.
5. Pompa G, Montesissa C, Di Lauro FM, and Fadini L. The metabolism of zearalenone insubcellular fraction from rabbit and hen hepatocytes and its oestrogenic activity in rabbits. Toxicology, 1986, 42, 69-75.
6. Mirocha CJ, Pathre SV, and Robison TS. Comparative metabolism of zearalenone and transmission into bovine milk. Food & Cosmetic Toxicology. 1981, 19, 25-30.
7. Fitzpatrick DW, Arbuckle LD, and Hassen AM. Zearalenone metabolism and excretion in the rat: effect of different doses. J. Environ. Sci. Health - Part B: Pesticides, Food Contaminants, & Agricultural Wastes, 1988, 23, 343-354.
8. Olsen M, Malmof K, Pettersson H, Sandholm K, and Kiessling K-H. Plasma and urinary levels of zearalenone and α-zearalenol in a prepubertal gilt fed zearalenone. Acta Pharmac. Tox. 1985, 56, 239-243.
9. Thouvenot D, Morfin R., Di Sterano S, and Picart D. Transformations of zearalenone and α-zearalenol by homogenates of human prostate glands. Eur. J. Biochem., 1981, 121, 139-145.
10. Dehal SS and Kupfer, D. Metabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B. Drug Metab. Dispos., 1994, 22, 937-946.
11. Kupfer D, Bulger WH, and Theoharides AD. Metabolism of methoxychlor by hepatic P450 monoxygenase in rat and human. 1. Characterization of a novel catechol metabolite. Chem. Res. Toxicol., 1990, 3, 8-16.
12. Li HC, Dehal SS, and Kupfer D. Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism. J. Biochem. Toxicol. 1995, 10, 51-61.
13. Spivack J, Leib TK, and Lobos JH. Novel pathway for bacterial metabolism of bisphenol A. J. Biol. Chem. 1994, 269, 7323-7329.
14. Knaak J and Sullivan LJ. Metabolism of bisphenol A in the rat. Toxic. Applied Pharmac. 1966, 8, 175-184.
15. Atkinson A and Roy D. In vitro conversion of oestrogenic compound bisphenol A to DNA binding metabolites. Biochem. Biophys. Res. Commun. 1995, 210, 424-433.
16. Atkinson A and Roy D. In vivo genotoxicity of bisphenol A. Environ. Mutagen. 1995, 26, 60-66.
17. Wallcave L, Bronczyk S, and Gingell R. Excreted metabolites of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane in the mouse and hamster. J. Agric. Food Chem. 1974, 22, 904-908.
18. Gold B and Brunk G. A mechanistic study of the metabolism of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane (DDD) to 2,2-bis(p-chlorophenyl)acetic acid (DDA). Biochem. Pharmcol. 1984, 33, 979-982.
19. Gold B and Brunk G. The effect of subchronic feeding of 1,1-dichloro-2,2-bis(4′-chlorophenyl)ethene (DDE) on its metabolism. Carcinogenesis 1986, 7, 1149-1153.
20. Moir D, Marwood TM, and Moody RP. In vitro cutaneous metabolism of DDT in human and animal skins. Bull Environ. Contam. Toxicol., 1994, 52, 474-478.
21. Saxena SP, Khare C, Farooq A, Murugesan K, Buckshee K, and Chandra J. DDT and its metabolites in leiomyomatous and normal human uterine tissue. Arch. Toxicol. 1987, 58, 453-455.
22. Ekborn A, Wicklund-Glynn A, and Adami H-O. DDT and testicular cancer. Lancet 1996, 347, 553-554.
23. Mahato SB, Banerjee S, Mukherjee A, and Kumar R. Metabolism of sitosterol by a pseudomonas species. Biochem. J., 1981, 196, 629-631.
24. Ambrus G, Ilkoy E, Jekkel A, Horvath G, and Bocskei Z. Microbial transformation of beta-sitosterol and stigmasterol into 26-oxygenated derivates. Steroids, 1995, 60, 621-625.
25. Subbiah MTR and Kuksis A. conversion of β-sitosterol to steroid hormones by rat testes in vitro. Experientia, 1975, 31, 763-764.
26. Boberg KM, Lund E, Olund J, and Bjorkhem I. Formation of C21 bile acids from plant sterols in the rat. J. Biol. Chem. 1990, 265, 7967-7975.
27. Sfakianos J, Coward L, Kirk M, and Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 1997, 127, 1260-1268.
28. Adlercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G, and Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scandinavian J. Clin. Lab. Invest. - Suppl., 1993, 215, 5-18.
29. Adlercreutz H, van der Wildt J, Kinzel J, Attalla H, Wahala K, Makela T, Hase T, and Fotsis T. Lignan and isoflavonoid conjugates in human urine. J. Steroid. Biochem. Molec. Biol. 1995, 52, 97-103.
30. Metzler M. The metabolism of diethylstilbestrol. CRC Crit. Rev. Biochem. 1981, 10, 171-212.
31. Zhu BT, Roy D, and Liehr JG. The carcinogenic activity of ethinyl oestrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology, 1993, 132, 577-583.
32. Mani C and Kupfer D. Cytochrome P450-mediated activation and irreversible binding of the anti-oestrogens Tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in Tamoxifen activation. Cancer Res, 1991, 51, 6052-6058.
33. Josephy PD, Mannervik B and Ortiz de Montellano P. Polycyclic aromatichydrocarbon carcinogenesis. In: Molecular Toxicology, Oxford University Press, Oxford, 1997, Chapter 19, pp. 315-351.
34. Zhu BT and Liehr JG. Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. J. Biol. Chem. 1996, 271, 1357-1363.